N-Ethylpentylone

N-Ethylpentylone
Clinical data
ATC code	none;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule I; DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B; US: Schedule I; UN: Psychotropic Schedule II;
Identifiers
	IUPAC name 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one;
CAS Number	727641-67-0 ; HCl: 17763-02-9 ;
PubChem CID	57359308;
ChemSpider	26949655;
UNII	D3H9D57JV9; HCl: S3G8XZW25I ;
KEGG	C22710 ;
CompTox Dashboard (EPA)	DTXSID701336299 ;
Chemical and physical data
Formula	C14H19NO3
Molar mass	249.310 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCNC(CCC)C(=O)c2ccc1OCOc1c2;
	InChI InChI=1S/C14H19NO3/c1-3-5-11(15-4-2)14(16)10-6-7-12-13(8-10)18-9-17-12/h6-8,11,15H,3-5,9H2,1-2H3; Key:VERDHJIMZYXGIW-UHFFFAOYSA-N;

N-Ethylpentylone (β-keto-ethylbenzodioxolylpentanamine, βk-ethyl-K, βk-EBDP, ephylone) is a substituted cathinone and stimulant drug which was developed in the 1960s.

It has been reported as a novel designer drug in several countries including the United Kingdom, South Africa, New Zealand, the United States, and Australia. In 2018, N-ethylpentylone was the most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.

Clinical data


ATC code	none
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics) CA: Schedule I DE: Anlage II (Authorized trade only, not prescriptible) UK: Class B US: Schedule I UN: Psychotropic Schedule II
Identifiers
IUPAC name 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one
CAS Number	727641-67-0^Y HCl: 17763-02-9^Y
PubChem CID	57359308
ChemSpider	26949655
UNII	D3H9D57JV9 HCl: S3G8XZW25I^Y
KEGG	C22710^Y
CompTox Dashboard (EPA)	DTXSID701336299
Chemical and physical data
Formula	C₁₄H₁₉NO₃
Molar mass	249.310 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCNC(CCC)C(=O)c2ccc1OCOc1c2
InChI InChI=1S/C14H19NO3/c1-3-5-11(15-4-2)14(16)10-6-7-12-13(8-10)18-9-17-12/h6-8,11,15H,3-5,9H2,1-2H3 Key:VERDHJIMZYXGIW-UHFFFAOYSA-N